Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meditoxin in Children With Cerebral Palsy
NCT01256021Phase 4Completed
- Sponsor
- Medytox Inc.
- Start
- Aug 2010
- Primary completion
- Feb 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Meditoxin in cerebral palsy (CP), sponsored by Medytox Inc. Primary endpoint: Modified Ashworth Scale at 4 weeks. Started Aug 2010; status: completed.
02
Drugs
Meditoxin
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT01256021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01256021.